The Europe Antimicrobial Susceptibility Testing Market should witness market growth of 5.5% CAGR during the forecast period (2022-2028).
The healthcare sector is developing interest in the antimicrobial susceptibility testing market due to increased demand for automated products, including AST panels, AST cards, and high-tech automated systems that provide more accuracy, faster processing, and enhanced workflow. This results in an increase in the use of automated systems in pharmaceutical & biotechnology companies, creating a tremendous growth opportunity for the market.
In addition, opportunities exist in unexplored, emerging markets with great potential due to enhanced healthcare infrastructure, growth in unmet healthcare demands, and increased antibiotic resistance among populations. The antimicrobial susceptibility testing market is ripe for investment by industry leaders due to the availability of manual and automated testing products that provide results in less time and with greater precision.
The increasing incidence of disease burden has prompted biopharmaceutical companies to create effective medications to combat the proliferation of infectious diseases. In 2015, the Federal Government expanded DART and revised its objectives. The German Antimicrobial Resistance Strategy (DART) 2020 is a nationwide, cross-sectoral strategy statement from 2015 to 2020. DART 2020 has the following objectives: recognizing resistance changes at an early stage; retaining and improving therapy options; strengthening the One Health approach; breaking infection chains early and preventing infections; raising awareness and enhancing skills; and supporting research & development. The regional market's growth is anticipated to be facilitated by government initiatives.
The Germany market dominated the Europe Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $328.7 million by 2028. The UK market is anticipated to grow at a CAGR of 4.6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 6.3% during (2022-2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
The healthcare sector is developing interest in the antimicrobial susceptibility testing market due to increased demand for automated products, including AST panels, AST cards, and high-tech automated systems that provide more accuracy, faster processing, and enhanced workflow. This results in an increase in the use of automated systems in pharmaceutical & biotechnology companies, creating a tremendous growth opportunity for the market.
In addition, opportunities exist in unexplored, emerging markets with great potential due to enhanced healthcare infrastructure, growth in unmet healthcare demands, and increased antibiotic resistance among populations. The antimicrobial susceptibility testing market is ripe for investment by industry leaders due to the availability of manual and automated testing products that provide results in less time and with greater precision.
The increasing incidence of disease burden has prompted biopharmaceutical companies to create effective medications to combat the proliferation of infectious diseases. In 2015, the Federal Government expanded DART and revised its objectives. The German Antimicrobial Resistance Strategy (DART) 2020 is a nationwide, cross-sectoral strategy statement from 2015 to 2020. DART 2020 has the following objectives: recognizing resistance changes at an early stage; retaining and improving therapy options; strengthening the One Health approach; breaking infection chains early and preventing infections; raising awareness and enhancing skills; and supporting research & development. The regional market's growth is anticipated to be facilitated by government initiatives.
The Germany market dominated the Europe Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $328.7 million by 2028. The UK market is anticipated to grow at a CAGR of 4.6% during (2022-2028). Additionally, The France market would exhibit a CAGR of 6.3% during (2022-2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology & Others
By Method
- Automated Susceptibility Testing Instruments
- Disk Diffusion
- Etest Method
- Agar Diffusion
- Genotyping Method
By Type
- Antibacterial
- Antifungal
- Antiparasitic
- Others
By End-user
- Hospitals & Diagnostic centers
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Clinical Research Organizations
By Product
- Automated Laboratory Instruments
- Manual Laboratory Instruments
- Culture & Growth Media
- Consumables
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Antimicrobial Susceptibility Testing Market by Application
Chapter 5. Europe Antimicrobial Susceptibility Testing Market by Method
Chapter 6. Europe Antimicrobial Susceptibility Testing Market by Type
Chapter 7. Europe Antimicrobial Susceptibility Testing Market by End-user
Chapter 8. Europe Antimicrobial Susceptibility Testing Market by Product
Chapter 9. Europe Antimicrobial Susceptibility Testing Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- BioMérieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
Related Reports
From
From
From
Antimicrobial Susceptibility Testing Global Market Report 2024
- Report
- 200 Pages
- Global
From
Antimicrobial Susceptibility Testing - Global Strategic Business Report
- Report
- 382 Pages
- Global
From
About the Antimicrobial Susceptibility Testing Market
The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
